Work

Risk Factors for Thromboembolism (TE) in Multiple Myeloma (MM) Patients (pts) Treated with Immunomodulatory Agents (IMiDs) Plus Dexamethasone (dex)

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-118283

Authors: Jai N Patel, Megan Helena Jagosky, Myra M Robinson, Daniel Slaughter, Justin Arnall, Ashley Matusz-Fisher, Manisha Bhutani, Peter M. Voorhees, Saad Z. Usmani

Institutions: Levine Cancer Institute, Carolinas Healthcare System

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2904220679

Cites:

Cited by:

Related to: 10